HIV DRUG RESISTANCE IN CASES OF PERINATAL TRANSMISSION IN IMPAACT 2010 (VESTED)
Background: VESTED was a multicenter open-label, randomized phase III trial comparing the safety and efficacy of dolutegravir (DTG)- and efavirenz (EFV)-based regimens in pregnant and breastfeeding women. Perinatal transmission to the infant occurred in 4/617 (0.6%) mother-infant pairs. This sub-study evaluated HIV drug resistance (HIVDR) in these 4 mother-infant pairs. Methods: Pregnant women with HIV…